| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 07/21/2005 | WO2005065150A2 Mutagenic heterocycles |
| 07/21/2005 | WO2005042712A3 Heterocyclic compounds and methods of making and using thereof |
| 07/21/2005 | WO2005023815A3 Neuroprotective bicyclic compounds and methods for their use |
| 07/21/2005 | US20050159596 Cyclic compounds and their use as complex ligands |
| 07/21/2005 | US20050159595 dry milling titanyl phthalocyanines and derivatives to form dry amorphous organic pigment mixtures, then heating to form crystal structures used in electrography |
| 07/21/2005 | US20050159460 2-[(1R,3S,4S)-1-benzyl-4-t-butoxycarbonylamino-3-hydroxy-5-phenylpentyl]-5-butyl-thiazole; for inhibiting beta-secretase-mediated cleavage of amyloid precursor protein, particularly to inhibit production of A beta peptide; treatment of diseases associated with a pathological form of A beta peptide |
| 07/21/2005 | US20050159451 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 07/21/2005 | US20050159436 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| 07/21/2005 | US20050159434 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents |
| 07/21/2005 | US20050159427 N-acylsulfonamide apoptosis promoters |
| 07/21/2005 | US20050159422 Inhibitors of akt activity |
| 07/21/2005 | US20050159420 Disruption of signal transduction by inhibition of kinases in target cells |
| 07/21/2005 | US20050159413 selective for matrix metalloprotease 13 (MMP-13) over other MMPs and also over reprolysins such as TNF-alpha converting enzyme (TACE) and aggrecanase; anticancer, antiinflammatory; 1-[6-(4-Fluoro-phenoxy)-pyridin-3-yl]-1,8,10-triaza-spiro[5.5]undecane-2,7,9,11-tetraone |
| 07/21/2005 | US20050159409 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence |
| 07/21/2005 | US20050159401 Treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation; forming a complexes with a reducing agent, penetrate and accumulate more rapidly in tumor cells, plaque, increase drug in intracellular concentration; increase photosensitivity |
| 07/21/2005 | US20050159391 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs |
| 07/21/2005 | US20050159341 Scaffolded maleimide clusters for multivalent peptide assembly |
| 07/21/2005 | US20050158584 Emissive layer includes platinum octaethylporphine, which emits radiation from a triplet molecular excited state rapidly enough to be used in displays (quantum yield of >50%; 90% in the solid state); highly saturated red emission; shelf life; vehicles; computers; television; large screens/signs |
| 07/21/2005 | DE10360835A1 New bicyclic imidazole derivatives are dipeptidylpeptidase-IV inhibitors useful to treat e.g. arthritis, obesity, allograft transplantation and calcitonin-induced osteoporosis |
| 07/21/2005 | CA2550869A1 Process for the preparation of phthalocyanines |
| 07/21/2005 | CA2550717A1 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof |
| 07/21/2005 | CA2548283A1 Mutagenic heterocycles |
| 07/20/2005 | EP1554281A2 Process for preparing certain pyrrolotriazine compounds |
| 07/20/2005 | EP1554280A2 Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors |
| 07/20/2005 | EP1554279A1 Process for the preparation of zaleplon |
| 07/20/2005 | EP1554277A1 Pyrrolo (3,4-c) carbazole and pyrido (2,3-b) pyrrolo (3,4-e) indole derivatives, preparation method and pharmaceutical compositions containing same |
| 07/20/2005 | EP1554272A1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 07/20/2005 | EP1554267A1 Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 07/20/2005 | EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 07/20/2005 | EP1381606B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 07/20/2005 | EP1303514B1 Process for preparing azacycloalkanoylaminothiazoles |
| 07/20/2005 | EP1244672B1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 07/20/2005 | EP1185493B1 Quinones for treatment of diseases |
| 07/20/2005 | EP1056717B1 Arylphenyl-substituted cyclic keto-enols |
| 07/20/2005 | EP1047677B1 Process for the preparation of derivatives of 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid |
| 07/20/2005 | CN1642957A Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances |
| 07/20/2005 | CN1642954A Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |
| 07/20/2005 | CN1642949A Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods |
| 07/20/2005 | CN1642937A Process for making chiral 1, 4-disubstituted piperazines |
| 07/20/2005 | CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642924A Anxiolytic agents with reduced sedative and ataxic effects |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |
| 07/20/2005 | CN1642905A Multidentate ligand, polynuclear metal complex, metal complex chain, metal complex assembly and production thereof |
| 07/20/2005 | CN1642550A Beta-sheet mimetics and composition and methods relating thereto |
| 07/20/2005 | CN1642541A Method for treating cognitive disorders |
| 07/20/2005 | CN1641768A Optical recording medium and novel azaporphyrin compounds |
| 07/20/2005 | CN1211386C Antitumoral analogue of Et-743 |
| 07/20/2005 | CN1211385C Bicyclic imidazo-5-yl-amine derivs. |
| 07/20/2005 | CN1211344C Process for prepn. of cyclopropyl carboxylic acid esters and derivatives |
| 07/19/2005 | US6919453 An azo dyes comprising 1,2,4-triazolo(4,3-a)(1,3, 5)triazine derivatives; chromogens, organic pigments |
| 07/19/2005 | US6919450 Process for the preparation of benazepril |
| 07/19/2005 | US6919448 Carbene porphyrins and carbene porphyrinoids, methods of preparation and uses thereof |
| 07/19/2005 | US6919359 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
| 07/19/2005 | US6919355 Amide derivatives as NMDA receptor antagonists |
| 07/19/2005 | US6919341 Imidazo(1,2-a)pyrazine compounds |
| 07/19/2005 | US6919340 Kinase moderators; controlling gene expression; immunosuppressants; autoimmune disease; rheumatic disorders; skin disorders; antitumor agents; anticancer agents |
| 07/19/2005 | US6919327 Texaphyrin coordination compounds and uses thereof |
| 07/19/2005 | US6918958 Acid pigment dispersants and pigment preparations |
| 07/14/2005 | WO2005063767A2 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 07/14/2005 | WO2005063766A2 Bicyclic heterocyclic p-38 kinase inhibitors |
| 07/14/2005 | WO2005063765A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 07/14/2005 | WO2005063764A2 Fused pyrrolocarbazoles and methods for the preparation thereof |
| 07/14/2005 | WO2005063763A1 Novel fused pyrrolocarbazoles |
| 07/14/2005 | WO2005063762A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 07/14/2005 | WO2005063761A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 07/14/2005 | WO2005063760A1 C-8 LINKED PYRROLO[2,1-c][1,4]BENZODIAZEPINE-ACRIDONE/ACRIDINE HYBRIDS |
| 07/14/2005 | WO2005063759A1 PROCESS FOR PREPARING PYRROLO[2, 1-c] [1, 4] BENZODIAZEPINE HYBRIDS |
| 07/14/2005 | WO2005063758A1 C2-FLUORO PYRROLO[2,1-c][1,4]BENZODIAZEPINE DIMERS |
| 07/14/2005 | WO2005063757A2 Novel crystalline forms of temozolomide |
| 07/14/2005 | WO2005063756A1 Crf receptor antagonists and methods relating thereto |
| 07/14/2005 | WO2005063755A1 Crf receptor antagonists and methods relating thereto |
| 07/14/2005 | WO2005063753A1 Process for the preparation of triazolopyrimidines |
| 07/14/2005 | WO2005063750A1 Bicyclic imidazole compounds, the production thereof and their use as medicaments |
| 07/14/2005 | WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 07/14/2005 | WO2005063251A1 Modified stent useful for delivery of drugs along stent strut |
| 07/14/2005 | WO2005063241A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates |
| 07/14/2005 | WO2005063239A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/14/2005 | WO2005046674A3 Antibacterial compositions |
| 07/14/2005 | WO2005034837A3 7H-IMIDAZO [1,2-α] PYRAZIN-8-ONE COMPOUNDS AS ION CHANNEL MODULATORS |
| 07/14/2005 | WO2005023816A3 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compouds and uses thereof |
| 07/14/2005 | US20050154202 Substituted aryl amides |
| 07/14/2005 | US20050154199 Bridged macrocyclic module compositions |
| 07/14/2005 | US20050154023 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease |
| 07/14/2005 | US20050154012 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/14/2005 | US20050154005 Administering to a subject in need of such treatment an effective amount of 1,1'-[1,4-(phenylenebis(methylene))]bis-1,4,8,11-tetraazacyclotetradecane or a pharmaceutical composition thereof, wherein the inhibition of CXCR4 receptor binding effects treatment or amelioration of said condition |
| 07/14/2005 | US20050154004 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one's and analogues, optionally mixed with acceptable carriers, excipients or diluents, used for treating multidrug resistant tumors, for inducing apoptosis and as immunology modulators |
| 07/14/2005 | US20050153992 Glycogen synthase kinase-3 inhibitors; pyrrolo[3,2-d]pyrimidine: neurodegenerative diseases; antidiabetic, antiinflammatory, anticancer agents; 5-(2-aminoethyl)-6-(3-chloro(2-thienyl))-7-iodo-3-hydropyrrolo[3,2-d]pyrimidin-4-thione Trifluoroacetate; 4-halo intermediates |
| 07/14/2005 | US20050153989 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
| 07/14/2005 | US20050153988 Novel polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| 07/14/2005 | US20050153966 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 07/14/2005 | US20050153955 Compounds and compositions as protein kinase inhibitors |
| 07/14/2005 | US20050153942 Heterocyclic inhibitors of MEK and methods of use thereof |
| 07/14/2005 | US20050152913 Process for preapring maytansinol |
| 07/14/2005 | US20050151467 Electrochromic salts, solutions, and devices |
| 07/14/2005 | DE10360370A1 Triazolopyrimidine Triazolopyrimidines |
| 07/14/2005 | CA2552095A1 Novel crystalline forms of temozolomide |
| 07/14/2005 | CA2551611A1 Thiazole derivatives for treating or preventing parkinson's disease |
| 07/14/2005 | CA2550948A1 Crf receptor antagonists and methods relating thereto |
| 07/14/2005 | CA2550689A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 07/14/2005 | CA2550649A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |